Latest: 5 upcoming webinars to boost your research
Latest: Combatting a ‘hidden pandemic’ with resistance-guided therapy
Latest: 5 essential resources to streamline your drug discovery and development processes
Latest: Top-rated lab products awarded new Seals of Quality
Latest: Simplifying scientific discovery: A new liquid handling solution with ease-of-use at its...
Latest: The trick(s) to brewing quality beer: A microbiology perspective
Latest: Akoya Biosciences unveils comprehensive roadmap of innovations at inaugural spatial day...
How collaboration and communication drives quality in protein production
Combatting a ‘hidden pandemic’ with resistance-guided therapy
Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of...
The Native Antigen Company expands range of norovirus-like particles
5 upcoming webinars to boost your research
The gut microbiome: Your questions answered
A guide to efficient and greener cannabinoid purification
Increasing LC-MS accessibility for streamlined biotherapeutic analysis
Qualitative and quantitative evaluation of the tissue microenvironment by high-resolution 17-plex...
Eliminating the logistical challenges of NMR data processing with browser-based software
Covid-19 ELISA Assays by Biorbyt
Targeted quantitation of legacy and emerging per- and polyfluoroalkyl substances (PFAS) in water
Cell Analysis Microscopy Equipment
Biophysical Characterization Technology
Virtual Clinical Science Summit
Virtual Cancer & Immunology Research Summit
05 Feb 22 - 09 Feb 22
Analytical Science Summit...
15 Feb 22 - 15 Feb 22
NEW: Infectious Disease &...
01 Mar 22 - 07 Mar 22
PITTCON Conference and Expo...
05 Mar 22 - 09 Mar 22
04 Apr 22 - 08 Apr 22
This white paper provides an overview of the pharma-compliant Cubis® II balance series, outlining its technical solutions for compliance and connectivity.
Download this Article